The Japanese Medical Device Agency has renewed Certara's license for the Simcyp and Phoenix biosimulator software. Simcyp Physiological is used in drug development to determine the right dose for humans. The Phoenix Pharmacokinetic platform helps drug developers save time by optimizing data management.